← All compounds
Best Price
Cheapest · 30mg
$99.99
$3.33/mg at AMC Essentials
Buy at AMC Essentials →Compare all 5 sources ↓
peptide5 sources in stock

ARA-290

ARA-290 (Cibinetide)

Erythropoietin-derived peptide. Neuropathy and tissue-repair research.

Neuropathy researchTissue repairAnti-inflammatory research
↓ Prices↓ Dosing↓ Research

For research use only · Not for human consumption

/ compare by size

Every source for ARA-290

Affiliate disclosure: purchases through links below may earn us a commission. Rankings are never sold — methodology · full disclosure

Size:
3 sources for 10mg·cheapest $36.00 at Ascension Peptides (with code)·$8.00/mg
#1
Ascension PeptidesBEST
★ 4.8
$79.99
$36.00
with code
Buy at Ascension Peptides →
#2
Welli Labs
★ 4.6
$39.99
$4.00/mg
Buy at Welli Labs →
#3
AMP Peptides
★ 4.8
$48.00
$4.80/mg
Buy at AMP Peptides →
🏆Our pick for ARA-290
Ascension Peptides
10mg · USA · Card / Crypto / Zelle
  • ✓Third-party tested (Janoshik)
  • ✓COAs provided — Per-batch core, quarterly bonus
  • ✓Within 8% of cheapest, higher verification tier
  • ✓4.8★ community rating
$79.99
$3.60/mg
Buy at Ascension Peptides →
Affiliate link · disclosure
Also solid
AMP Peptides
10mg · $4.80/mg
$48.00
Buy →
AMC Essentials
30mg · $3.33/mg
$99.99
Buy →
Welli Labs
10mg · $4.00/mg
$39.99
Buy →
How we pick sources →
/ research index

The research base

Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★☆☆
3/5 — Quality of evidence

Innate repair receptor agonist studied for neuropathic pain and tissue protection without erythropoietic effects.

/ mechanism of action

How it works

Activates the innate repair receptor (IRR), modulating inflammation and promoting tissue repair without affecting red blood cell production.

/ research dosing

Common research protocols

Range
1-4 mg/day (trials used ~2-4mg subQ)
Frequency
Daily subcutaneous
Route
Subcutaneous
Cycle
4-12 week research courses
Research notes

Derived from the EPO molecule but lacks erythropoietic activity. Studied for small-fiber neuropathy and sarcoidosis-related pain.

References
PMID: 26926342 →PMID: 24622315 →
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use

As a solo compound

Standalone use is standard for neuropathy research.

Common pairings
/ side effects

What to know

Generally well-tolerated in trials; injection-site effects possible.

/ timeline

Realistic expectations

4-8 weeks

FOR RESEARCH USE ONLY. ARA-290 is intended for laboratory research and not for human consumption.